//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~isPartOf:"The European journal of health economics : HEPAC ; health economics in prevention and care"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Cost Effectiveness of the New...
Similar by person
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Arzneimittel
6
Pharmaceuticals
6
Pharmaceutical industry
4
Pharmaindustrie
4
Arzneimittelmarkt
2
EU countries
2
EU-Staaten
2
Italien
2
Italy
2
Pharmaceutical market
2
Arbeitskampf
1
Arbeitskonflikt
1
Auskunftspflicht
1
Basisgesundheitsversorgung
1
Competition
1
Corporate disclosure
1
Disclosure regulation
1
Droge
1
Drogenkonsum
1
Drug
1
Drug consumption
1
Europa
1
Europe
1
Generic drugs
1
Generika
1
Gesundheitskosten
1
Gesundheitspolitik
1
Gesundheitsversorgung
1
Gesundheitswesen
1
Health care
1
Health care costs
1
Health care system
1
Health policy
1
Industrial action
1
International competition
1
Internationaler Wettbewerb
1
Labour dispute
1
Preis
1
Price
1
Primary health care
1
more ...
less ...
Online availability
All
Undetermined
11
Type of publication
All
Article
17
Type of publication (narrower categories)
All
Article in journal
16
Aufsatz in Zeitschrift
16
Language
All
English
16
Undetermined
1
Author
All
Garattini, Livio
17
Padula, Anna
9
Curto, Alessandro
6
Van de Vooren, Katelijne
6
Freemantle, Nick
1
Vooren, Katelijne
1
Published in...
All
The European journal of health economics : HEPAC ; health economics in prevention and care
Health Policy
12
The European Journal of Health Economics
12
PharmacoEconomics
9
The European journal of health economics
7
Applied Health Economics and Health Policy
3
Economia pubblica : the Italian journal of public economics and law
3
Working Papers / Centre for Health Economics, Department of Economics and Related Studies
1
more ...
less ...
Source
All
ECONIS (ZBW)
16
OLC EcoSci
1
Showing
1
-
10
of
17
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Could co-payments on drugs help to make EU health care systems less open to political influence?
Garattini, Livio
;
Vooren, Katelijne
- In:
The European journal of health economics : HEPAC ; …
14
(
2013
)
5
,
pp. 709-713
Persistent link: https://www.econbiz.de/10010169392
Saved in:
2
Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial
Garattini, Livio
;
Curto, Alessandro
;
Van de Vooren, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
7
,
pp. 683-687
Persistent link: https://www.econbiz.de/10011482938
Saved in:
3
Access to primary care in Italy : time for a shake-up?
Garattini, Livio
;
Curto, Alessandro
;
Freemantle, Nick
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
2
,
pp. 113-116
Persistent link: https://www.econbiz.de/10011486395
Saved in:
4
Editorial: reimbursable drug classes and ceilings in Italy : why not only one?
Garattini, Livio
;
Curto, Alessandro
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
8
,
pp. 923-926
Persistent link: https://www.econbiz.de/10011660068
Saved in:
5
Pricing of forthcoming therapies for hepatitis C in Europe : beyond cost-effectiveness?
Van de Vooren, Katelijne
;
Curto, Alessandro
;
Garattini, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
4
,
pp. 341-345
Persistent link: https://www.econbiz.de/10011299737
Saved in:
6
Italian risk-sharing agreements on drugs : are they worthwhile?
Garattini, Livio
;
Curto, Alessandro
;
Van de Vooren, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
1
,
pp. 1-3
Persistent link: https://www.econbiz.de/10011300361
Saved in:
7
Editorial: market approval for drugs in the EU : time to change direction?
Curto, Alessandro
;
Van de Vooren, Katelijne
;
Garattini, …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
8
,
pp. 933-936
Persistent link: https://www.econbiz.de/10011869154
Saved in:
8
Conflict of interest disclosure : striking a balance?
Garattini, Livio
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
5
,
pp. 633-636
Persistent link: https://www.econbiz.de/10012060958
Saved in:
9
HTA for pharmaceuticals in Europe : will the mountain deliver a mouse?
Garattini, Livio
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
1
,
pp. 1-5
Persistent link: https://www.econbiz.de/10012221579
Saved in:
10
Defensive medicine in Europe : a "full circle"?
Garattini, Livio
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
2
,
pp. 165-170
Persistent link: https://www.econbiz.de/10012221652
Saved in:
1
2
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->